These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20588025)

  • 1. Intranuclear translocation signaling of HB-EGF carboxy-terminal fragment and mucosal defense through cell proliferation and migration in digestive tracts.
    Tanida S; Kataoka H; Mizoshita T; Shimura T; Kamiya T; Joh T
    Digestion; 2010; 82(3):145-9. PubMed ID: 20588025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells.
    Itoh Y; Joh T; Tanida S; Sasaki M; Kataoka H; Itoh K; Oshima T; Ogasawara N; Togawa S; Wada T; Kubota H; Mori Y; Ohara H; Nomura T; Higashiyama S; Itoh M
    Cytokine; 2005 Mar; 29(6):275-82. PubMed ID: 15749028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR ligands and their signaling scissors, ADAMs, as new molecular targets for anticancer treatments.
    Kataoka H
    J Dermatol Sci; 2009 Dec; 56(3):148-53. PubMed ID: 19896805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation.
    Kawakami A; Tanaka A; Chiba T; Nakajima K; Shimokado K; Yoshida M
    Circulation; 2003 Nov; 108(21):2679-88. PubMed ID: 14623816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells.
    Ebi M; Kataoka H; Shimura T; Kubota E; Hirata Y; Mizushima T; Mizoshita T; Tanaka M; Mabuchi M; Tsukamoto H; Tanida S; Kamiya T; Higashiyama S; Joh T
    Biochem Biophys Res Commun; 2010 Nov; 402(3):449-54. PubMed ID: 20934403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors.
    Sanderson MP; Dempsey PJ; Dunbar AJ
    Growth Factors; 2006 Jun; 24(2):121-36. PubMed ID: 16801132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectodomain shedding of membrane-anchored heparin-binding EGF like growth factor and subcellular localization of the C-terminal fragment in the cell cycle.
    Toki F; Nanba D; Matsuura N; Higashiyama S
    J Cell Physiol; 2005 Mar; 202(3):839-48. PubMed ID: 15389565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative and osmotic stress signaling in tumor cells is mediated by ADAM proteases and heparin-binding epidermal growth factor.
    Fischer OM; Hart S; Gschwind A; Prenzel N; Ullrich A
    Mol Cell Biol; 2004 Jun; 24(12):5172-83. PubMed ID: 15169883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HB-EGF promotes epithelial cell migration in eyelid development.
    Mine N; Iwamoto R; Mekada E
    Development; 2005 Oct; 132(19):4317-26. PubMed ID: 16141218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells.
    Romano M; Ricci V; Di Popolo A; Sommi P; Del Vecchio Blanco C; Bruni CB; Ventura U; Cover TL; Blaser MJ; Coffey RJ; Zarrilli R
    J Clin Invest; 1998 Apr; 101(8):1604-13. PubMed ID: 9541490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
    Mehta VB; Zhou Y; Radulescu A; Besner GE
    Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
    Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmin-induced smooth muscle cell proliferation requires epidermal growth factor activation through an extracellular pathway.
    Roztocil E; Nicholl SM; Galaria II; Davies MG
    Surgery; 2005 Aug; 138(2):180-6. PubMed ID: 16153425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor in cultured human retinal pigment epithelial cells.
    Yan F; Hui YN; Li YJ; Guo CM; Meng H
    Ophthalmologica; 2007; 221(4):244-50. PubMed ID: 17579290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase-dependent EGF receptor activation in hypertension and left ventricular hypertrophy.
    Shah BH; Catt KJ
    Trends Endocrinol Metab; 2004 Aug; 15(6):241-3. PubMed ID: 15358274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM; Saigal B; Donato NJ
    J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation.
    Luppi F; Longo AM; de Boer WI; Rabe KF; Hiemstra PS
    Lung Cancer; 2007 Apr; 56(1):25-33. PubMed ID: 17175059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telmisartan inhibits cell proliferation by blocking nuclear translocation of ProHB-EGF C-terminal fragment in colon cancer cells.
    Ozeki K; Tanida S; Morimoto C; Inoue Y; Mizoshita T; Tsukamoto H; Shimura T; Kataoka H; Kamiya T; Nishiwaki E; Ishiguro H; Higashiyama S; Joh T
    PLoS One; 2013; 8(2):e56770. PubMed ID: 23451083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of proHB-EGF carboxy-terminal fragment nuclear translocation: a new molecular target therapy for gastric cancer.
    Shimura T; Kataoka H; Ogasawara N; Kubota E; Sasaki M; Tanida S; Joh T
    Clin Cancer Res; 2008 Jun; 14(12):3956-65. PubMed ID: 18559618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.